Groundswell Movement
Together We Can Improve
Chronic Kidney Disease
Patient Outcomes Nationwide
The Facts
As many as 9 in 10 adults with chronic kidney disease (CKD) do not know they have it.
Early CKD has no signs or symptoms until it becomes severe.
1
1,2
Diabetes and hypertension are the leading causes of kidney failure in the United States, accounting for 3 out of 4 cases.
The interdependent relationship between heart disease, kidney disease, and metabolic disease (diabetes) defines cardio-renal-metabolic (CRM) disease. When one of these systems is negatively affected, it exerts negative effects on the other two.
3
CKD cost of care is steep. Medicare spends more than $85.4 billion annually on CKD and $50.8 billion on end-stage renal disease (ESRD).
4
The Care Gap
Despite guideline recommendations, proper testing for CKD in US adults with diabetes and hypertension—which is also a HEDIS (Healthcare Effectiveness Data and Information Set) measurement—is only done about 20% of the time in routine clinical care.
5
The Solution
Scalable behavior change that improves patient outcomes requires an integrated approach in today’s fragmented US healthcare system.
So QC-Health, Inc (a provider-focused benefit corp), Aventria Health Group (a secondary-provider-focused agency working with pharma, biotech, and medical devices), and Relentless Health Value podcast (focused on healthcare influencers) began collaborating to impact CKD outcomes.
We started a
A Groundswell Movement is a series of collaborations with healthcare stakeholders to change behavior in the way chronic disease patient populations are identified and treated. How? By engaging providers and patients with evidence-based knowledge and a digital care plan solution in the clinical workflow and tracking the measurable impact on patient outcomes and costs.
Come Join the CKD Groundswell Movement
Providers and payers: Find out about our free CKD digital care plan solution you can use to get patients with diabetes and/or hypertension diagnosed and staged using evidence-based guidelines.
Life sciences/CKD cost-containment solutions/Other for-profit companies: Consider sponsoring our work and discussing other ways to collaborate.
Healthcare consultants and others: Join us in helping the healthcare industry level up CKD care.
References: 1. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2023. Accessed August 29, 2023. https://www.cdc.gov/kidneydisease/pdf/CKD-Factsheet-H.pdf 2. Centers for Disease Control and Prevention. Chronic Kidney Disease Basics. Accessed August 29, 2023. https://www.cdc.gov/kidneydisease/basics.html 3. Kadowaki T, Maegawa H, Watada H, et al. Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan. Diabetes Obes Metab. 2022;24(12):2283-2296. 4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Healthcare Expenditures for Persons With CKD. Accessed August 29, 2023. https://usrds-adr.niddk.nih.gov/2022/chronic-kidney-disease/6-healthcare-expenditures-for-persons-with-ckd#:~:text=Total%20Medicare%20FFS%20spending%20for,(Tables%206.1%20and%206.2) 5. Alfego D, Ennis J, Gillespie B, et al. Chronic kidney disease testing among at-risk adults in the US remains low: real-world evidence from a national laboratory database. Diabetes Care. 2021;44(9):2025-2032.